Anuria as an Unusual Presentation of Recurrent FSGS Following Kidney Transplant: A Case Report

Introduction: Recurrent focal segmental glomerulosclerosis (FSGS) after kidney transplantation presents a significant challenge that can cause graft failure.This report highlights an unusal case where recurrent FSGS led to early anuria shortly after transplantation. Case Description: A 24-year-old male, diagnosed with primary FSGS since 2017 and end stage renal disease (ESRD) of two years, underwent a living donor kidney transplant from his mother in 2024. Pre-transplant evaluation showed no donor-specific antibodies (DSAs), negative crossmatches, and a CMV mismatch (D+/R-),So he started Valacyclovir as a prophylaxis. Post-operatively, the graft function was excellent initially. Patient urine output was 600-800 mL/hr with improving creatinine levels. By postoperative day 2 (POD 2), Urine output began to decline till the patient became anuric by POD 3. Renal Doppler and ultrasound were normal. Renal biopsy performed on POD 3 revealed acute tubular injury (ATI) with no signs of rejection or C4d positivity. Despite initial management with plasmapheresis and antithymocyteglobulin (ATG), the patient remained anuric. A second biopsy on POD 9 confirmed ATI. So, his immunosuppression was adjusted by reducing tacrolimus, initiating sirolimus, and switching valacyclovir to valganciclovir. On POD 16,Urine output began to increase. Electron microscopy (EM) revealed diffuse podocyte foot process effacement, confirming the diagnosis of recurrent FSGS.12 sessions of plasmapheresis were done and a single dose of obinutuzumab was given. At the last follow-up, he maintained stable graft function with a serum creatinine 1.05 mg/dL, though urine protein/creatinine ratio (1.5 g/day). Discussion: Recurrent FSGS remains a diagnostic and theraputic challenge in kidney transplantation. This case is unique due to its early, atypical presentation with anuric graft dysfunction. It shows the diagnostic challenges associated with early recurrence of primary FSGS post-transplant, where anuria may be the sole presenting feature. Electron microscopy plays an important role in confirming the diagnosis, particularly in cases where light microscopy fails to reveal glomerular pathology.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025zh1bk3kq
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anuria as an Unusual Presentation of Recurrent FSGS Following Kidney Transplant: A Case Report

Mahmoud Nady Abd El Aziz Abd El Azim, Ahmed Rady, Magdy ElSharkawy, Nahla Mohamed Teama et al.
Journal of the American Society of Nephrology
Renal Diseases and Glomerulopathies
article

Anuria as an Unusual Presentation of Recurrent FSGS Following Kidney Transplant: A Case Report

Mahmoud Nady Abd El Aziz Abd El Azim, Ahmed Rady, Magdy ElSharkawy, Nahla Mohamed Teama, Ahmed K. Emara, Shadia A. Fathy, Mohamed Abd El-Mohsen, Reem Mohsen Elsharabasy, Fatma Abdelrahman Ahmed, Abdelrahman Elbraky, Marwa Abdelrehim, Shaimaa Zaki abdelmegied Abdallah, Ramzy Shehata, Wedad Adel
article en

Abstract

Introduction: Recurrent focal segmental glomerulosclerosis (FSGS) after kidney transplantation presents a significant challenge that can cause graft failure.This report highlights an unusal case where recurrent FSGS led to early anuria shortly after transplantation. Case Description: A 24-year-old male, diagnosed with primary FSGS since 2017 and end stage renal disease (ESRD) of two years, underwent a living donor kidney transplant from his mother in 2024. Pre-transplant evaluation showed no donor-specific antibodies (DSAs), negative crossmatches, and a CMV mismatch (D+/R-),So he started Valacyclovir as a prophylaxis. Post-operatively, the graft function was excellent initially. Patient urine output was 600-800 mL/hr with improving creatinine levels. By postoperative day 2 (POD 2), Urine output began to decline till the patient became anuric by POD 3. Renal Doppler and ultrasound were normal. Renal biopsy performed on POD 3 revealed acute tubular injury (ATI) with no signs of rejection or C4d positivity. Despite initial management with plasmapheresis and antithymocyteglobulin (ATG), the patient remained anuric. A second biopsy on POD 9 confirmed ATI. So, his immunosuppression was adjusted by reducing tacrolimus, initiating sirolimus, and switching valacyclovir to valganciclovir. On POD 16,Urine output began to increase. Electron microscopy (EM) revealed diffuse podocyte foot process effacement, confirming the diagnosis of recurrent FSGS.12 sessions of plasmapheresis were done and a single dose of obinutuzumab was given. At the last follow-up, he maintained stable graft function with a serum creatinine 1.05 mg/dL, though urine protein/creatinine ratio (1.5 g/day). Discussion: Recurrent FSGS remains a diagnostic and theraputic challenge in kidney transplantation. This case is unique due to its early, atypical presentation with anuric graft dysfunction. It shows the diagnostic challenges associated with early recurrence of primary FSGS post-transplant, where anuria may be the sole presenting feature. Electron microscopy plays an important role in confirming the diagnosis, particularly in cases where light microscopy fails to reveal glomerular pathology.

Journal of the American Society of NephrologyVol. 36(10S)
Ain Shams University (EG)
Openalex Percentile: Top 60%
Renal Diseases and Glomerulopathies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.